Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Medical Journal of Cairo University [The]. 2003; 71 (1): 125-32
en Inglés | IMEMR | ID: emr-63602

RESUMEN

In this study, 70 patients with chronic liver failure [CRF] maintained on regular hemodialysis were divided into two groups according to the presence or absence of bony pains. The results showed that serum AL level was significantly higher in the group with bony pains [25.9 + 20.9 g/l and 13.88 + 5.6 g/l, respectively]; also, intact parathyroid hormone [iPTH] was significantly higher in the group with bony pains [432.77 + 244.20 pg/ml and 269.77 + 0.81 pg/l, respectively]. Bone densitometry was significantly lower in patients with bony aches [group A] than those with no bony aches [group B] in the neck of the femur and the mid radius. Hemoglobin level was significantly lower in the group with bony pains [7.4 + 1.2 g% and 11.3- 1.5 g%, respectively]; also, serum ferritin level was significantly higher in the group with bony pains [249.126.1 mg% and 714.38.7 mg%, respectively]


Asunto(s)
Humanos , Masculino , Femenino , Aluminio/sangre , Densidad Ósea , Absorciometría de Fotón , Ferritinas/sangre , Pruebas de Función Renal
2.
Medical Journal of Cairo University [The]. 2003; 71 (Supp. 2): 119-127
en Inglés | IMEMR | ID: emr-63813

RESUMEN

In this study, serum and urinary transforming growth factor beta 1 [TGF- beta 1] and platelet derived growth factor [PDGF] levels were determined by enzyme-linked immunosorbent assay [ELISA] in ten renal allograft recipients for more than one year with normal renal function [group I], ten renal allograft recipients for more than one year with impaired renal function [group II] and ten patients with chronic renal failure [CRF] under conservative therapy [group III] and the measurements were compared with the levels of ten healthy controls [group IV]. The data confirmed the crucial contribution of the profibrotic cytokines TGF-beta 1 and PDGF in the development of chronic graft dysfunction that could be further augmented by cyclosporine A therapy. Further studies are needed to examine the effect of manipulation of immunosuppressive regimen on the extent of profibrotic gene expression as well as the long-term graft survival


Asunto(s)
Humanos , Masculino , Femenino , Trasplante Homólogo , Supervivencia de Injerto , Factor de Crecimiento Transformador beta/orina , Ciclosporina , Pruebas de Función Hepática , Pruebas de Función Renal , Factor de Crecimiento Derivado de Plaquetas/orina , Citocinas/orina , Citocinas/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA